Work

Bilateral Panocular Involvement With Mantle-Cell Lymphoma

Year: 2008
Type: article
Study design: Case Report
Abstract: A 51-year-old white woman presented with complaints of bilateral red eye of 2 weeks duration associated with photophobia and blurred vision.Seventeen months prior, she had begun a series of chemotherapy regimens for mantle-cell lymphoma (MCL), confirmed by fluorescent in situ hybridization and flow cytometry, that culminated in autologous stem-cell transplantation.On presentation to our clinic, she was receiving rituximab in combination with intrathecal cytarabine for leptomeningeal involvement.Visual acuity was 20/40 in the right eye and count fingers at 1 foot in the left eye.External examination revealed multiple cutaneous eyelid nodules bilaterally and a salmon patch of the bulbar conjunctiva of the right eye (Fig 1).Slit-lamp examination was significant for pseudohypopyon (lymphocytes in the anterior chamber), irregular stromal thickening of the iris, and infiltration of the vitreous with lymphocytes (left eye more than right) bilaterally (Figs 1 and 2), indicative of anterior and posterior chamber involvement of both eyes with lymphoma.She was placed on hourly prednisone eye drops.In addition, external-beam radiation treatment (EBRT) at a dose of 14 Gy (2 Gy in seven fractions) was administered as a cone down to the area of gross ocular disease, with an additional dose of 16 Gy (2 Gy in eight fractions) to the brain.One week after initiation of EBRT, ocular signs had resolved dramatically and visual acuity was 20/40 in the right eye and 20/50 in the left eye.In addition, the conjunctival salmon patch, pseudohypopyon, iris stromal changes, and vitreous lymphocytic infiltration had resolved bilaterally (Fig 3).The patient was started on tositumomab for widespread cutaneous involvement, and at most recent examination 7 weeks after initial presentation, ocular examination was unremarkable.MCL, a subtype of B-cell non-Hodgkin's lymphoma (NHL), comprises 6% to 7% of all NHL. 1 In a review of case series, a relatively small proportion (median 4%, n ϭ 11) of histologically confirmed ocular lymphoma were classified as MCL. 2 In general, ocular adnexal lymphoma is not associated with intraocular involvement.2 Patients with mantle-cell lymphoma typically respond poorly to conventional chemotherapy, and thus exhibit the worst overall survival of the NHL subtypes, with a 27% 5-year survival after treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone.3 Until more effective systemic therapy is developed, we submit evidence that ocular morbidity may be alleviated with the use of localized EBRT.
Institution: Cleveland Clinic
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2109775119
FWCI: 0.292
Cites: 3
Cited by: 11
Related to: 9